TNXP Stock Analysis: Buy, Sell, or Hold?
TNXP - Tonix Pharmaceuticals Holding Corp.
$13.68
-0.07 (-0.51%)
▼
5d:
-8.8%
30d:
-1.87%
90d:
-13.53%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
TNXP is down 14.1% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 110 OI. Call ratio: 88% View Scanner →
Strength: 10.0/10
Get Alerted When TNXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TNXP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TNXP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TNXP is currently trading at $13.68, which is considered oversold relative to its 30-day fair value range of $13.34 to $15.05.
Technical Outlook: Technically, TNXP is in a downtrend. Immediate support is located at $11.60, while resistance sits at $17.00.
Market Sentiment: TNXP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $54.33 (+297.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TNXP is in a downtrend. Immediate support is located at $11.60, while resistance sits at $17.00.
Market Sentiment: TNXP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $54.33 (+297.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$13.34 -
$15.05
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 297.2% below Wall St target ($54.33)
- CAUTION: 5-day price weakness (-8.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$13.34 -
$15.05
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$11.60
Resistance Level
$17.00
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.70
Wall Street Target
$54.33
(+297.2%)
Revenue Growth (YoY)
108.8%
Share & Embed Analysis
Last updated: April 02, 2026 4:33 AM ET
Data refreshes hourly during market hours. Next update: 5:33 AM
Data refreshes hourly during market hours. Next update: 5:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$134 | 61 BUY |
